Trial NCT00684255

View at ClinicalTrials.gov 
Org. Study IDs: AAAB1324
Secondary IDs: CHNY-01-511

Last trial update was posted on 2014-04-01

MeSH Interventions

Alemtuzumab Busulfan Fludarabine

MeSH Conditions

Lupus Erythematosus, Systemic Scleroderma, Diffuse Scleroderma, Systemic Sclerosis

Other Conditions

Systemic Lupus Erythematosus Systemic Sclerosis

Stopping Reasons

inactive

Limitations And Caveats

Study closed due to low accrual. Did not meet enrollment goals.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID